Attorney Jessica Paluch-Hoerman, founder of TruLaw, has over 28 years of experience as a personal injury and mass tort attorney, and previously worked as an international tax attorney at Deloitte. Jessie collaborates with attorneys nationwide — enabling her to share reliable, up-to-date legal information with our readers.
This article has been written and reviewed for legal accuracy and clarity by the team of writers and legal experts at TruLaw and is as accurate as possible. This content should not be taken as legal advice from an attorney. If you would like to learn more about our owner and experienced injury lawyer, Jessie Paluch, you can do so here.
TruLaw does everything possible to make sure the information in this article is up to date and accurate. If you need specific legal advice about your case, contact us by using the chat on the bottom of this page. This article should not be taken as advice from an attorney.
The hair straightening products Uterine Cancer lawsuit has been filed after a new study published in the Journal of the National Cancer Institute established the first epidemiologic evidence of a connection between hair straightening (or “hair relaxing”) products and uterine cancer.
The study, overseen by the National Institutes of Health (NIH), revealed that females who used chemical hair straightening products frequently (more than four times per year) were more than twice as likely to be diagnosed with uterine cancer than individuals who never used the products.
If you or someone you love used chemical hair straightening products consistently and were later diagnosed with uterine cancer, you could be entitled to seek compensation from the maker(s) of the product you used.
Companies have a legal responsibility to manufacture and sell safe products, and numerous companies seemingly failed to honor that obligation when they created hair straightening products using hazardous chemicals.
If you think your uterine cancer was caused by frequent exposure to hair-relaxing products, you deserve a chance to hold the manufacturer accountable for their negligence.
Contact TruLaw for a free, no-risk consultation to find out whether you have a case.
On October 24, 2022, The Washington Post and other outlets reported that a federal lawsuit was filed against L’Oréal and other cosmetics companies, alleging that hazardous chemicals found in their hair straightening products put consumers at an increased risk of developing uterine cancer.
The lawsuit was filed by Jenny Mitchell, who was forced to undergo a hysterectomy at 28 after being diagnosed with uterine cancer.
The lawsuit was filed just a short time after the NIH published the results of their study.
The study followed 33,497 Sister Study participants over 10+ years and confirmed a link between hair-relaxing products and uterine cancer.
The findings were especially concerning for Black women like Mitchell, who have reported using chemical hair straightening products at higher rates than other demographics.
Uterine cancer is more common among Black women than women in other groups, and tragically, Black women are also more likely to die due to uterine cancer than women from other demographics.
Still, anyone who developed uterine cancer after using chemical hair straightening products could be entitled to recover damages through a civil lawsuit.
If you meet these criteria, you might be able to pursue compensation for medical expenses, in-home care, lost income, lost quality of life, mental anguish, pain and suffering, and other losses.
To determine whether you qualify for a lawsuit, you should reach out to an experienced Illinois product liability lawyer at TruLaw.
Uterine cancer is an umbrella term for a group of cancers that affect the uterus.
The uterus, where unborn fetuses grow during pregnancy, is the primary component of the female reproductive system.
Some of the most common signs and symptoms of uterine cancer include:
There are two types of uterine cancer: endometrial cancer and uterine sarcoma.
Endometrial cancer is far more common than uterine sarcoma.
According to the American Cancer Society, it is the most prevalent cancer of the female reproductive system.
Endometrial cancer occurs in the inner lining of the uterus when cells there grow out of control and form a tumor.
A hysterectomy is typically the recommended course of treatment.
The other type of uterine cancer, uterine sarcoma, is a much rarer type of cancer than endometrial cancer.
It occurs in the muscle of the uterus as well as in surrounding tissues.
The American Cancer Society says that uterine sarcomas account for just two to five percent of uterine cancers.
The NIH study didn’t compile data on specific brands that participants used, but it did name numerous chemicals typically found in hair straightening products that could increase the likelihood of developing uterine cancer.
Those chemicals include:
The chemicals in hair straightening products have also been linked to breast cancer and other hormone-related cancers.
Women who regularly use hair straightening products may have a higher risk of developing uterine cancer when compared with people who don’t use these products.
Because hair straightening products (also called hair relaxers) are very popular with Black women, Black women may be more vulnerable to developing uterine cancer from these products than other groups.
Black women already pass away due to uterine cancer at double the rate of other racial and ethnic groups.
According to the University of Washington, the mortality rate for Black women with endometrial cancer is 39.1 percent.
For white women, it is 19.8 percent. In general, Black women have a 55 percent higher mortality rate for endometrial cancer than other demographics.
The attorneys at TruLaw are currently investigating claims that the chemicals found in hair relaxers can lead to uterine cancer.
If you believe you qualify for a lawsuit, you should contact a product liability attorney at TruLaw for a free, instant case evaluation.
The recent federal lawsuit filed by Jenny Mitchell has been called a “watershed moment” for women of color who were never warned about the dangers of frequently using hair straightening products by L’Oréal and other cosmetic companies.
The fact that many Black women straighten their hair because of societal pressures makes this issue even more tragic.
We will be monitoring the status of civil legal action against the manufacturers of hair straightening products as we gather prospective clients and work to assess the viability of hair product uterine cancer lawsuits.
Reach out to our legal team today if you think you might have a case.
We’ll review the details of your situation and discuss your legal options.
The association between hair relaxer products and uterine cancer is a topic of ongoing research and discussion in the scientific community.
Key Points:
Research has suggested a potential link between the use of hair relaxer products and an increased risk of uterine cancer.
However, it’s important to note that these findings are preliminary and not yet definitive.
While initial studies have indicated a potential connection, this link requires further investigation.
More comprehensive research is needed to conclusively establish the relationship between hair relaxer use and uterine cancer.
The risk of developing uterine cancer from hair relaxer use can be influenced by various factors.
These include genetic predisposition, lifestyle choices, and the frequency of product usage.
To conclude, while there is some evidence suggesting a link between hair relaxer use and uterine cancer, more research is needed to confirm this association.
Individual risk factors also play a significant role in determining the likelihood of developing this condition.
Legal recourse may be available for individuals who have developed health conditions after using chemical hair relaxers.
Key Points:
If you’ve developed health issues such as cancer, endometriosis, or uterine fibroids after using chemical hair relaxers, you may be able to pursue legal action.
This can provide compensation for medical expenses, lost wages, and other damages.
Numerous Hair Relaxer lawsuits have been filed against the manufacturers of these products.
These legal actions seek to hold the companies accountable for the health issues experienced by users of their products.
The Hair Relaxer lawsuits allege that the manufacturers of hair relaxer products did not sufficiently warn consumers about potential health risks.
This includes a heightened risk of developing conditions like uterine cancer.
To conclude, if you’ve developed health conditions after using chemical hair relaxers, pursuing legal action may be a viable option.
Manufacturers are currently facing lawsuits for allegedly failing to adequately inform consumers about the potential risks associated with their products.
The risk of uterine cancer for frequent users of hair straighteners is a subject of ongoing research.
Key Points:
Preliminary studies suggest that regular users of hair straighteners might face a higher risk of uterine cancer.
This potential link is a cause for concern and warrants further investigation.
It’s important to note that individual risk can vary greatly.
Factors such as genetic predisposition, lifestyle choices, and the frequency of product usage can all influence a person’s risk of developing uterine cancer.
While initial studies suggest a potential risk, more comprehensive research is necessary to definitively establish a correlation between the frequent use of hair straighteners and an increased risk of uterine cancer.
To conclude, while there is some evidence suggesting a higher risk of uterine cancer for frequent users of hair straighteners, more research is needed to confirm this link.
Individual risk factors also play a significant role in determining the likelihood of developing this condition.
The uterine cancer lawsuits related to hair relaxers involve several key claims against the manufacturers of these products.
Key Points:
The lawsuits claim that the manufacturers of hair relaxer products did not adequately inform consumers about the potential risks associated with their products.
This includes a possible increased risk of uterine cancer.
Some plaintiffs in these lawsuits allege that they developed health conditions, such as uterine cancer, after using hair relaxer products.
They argue that their health issues are a direct result of using these products.
The core of these lawsuits revolves around potential health hazards associated with the use of hair relaxer products.
The plaintiffs argue that the manufacturers failed to provide sufficient warning about these risks.
To conclude, the uterine cancer lawsuits related to hair relaxers primarily claim that manufacturers did not adequately warn consumers about potential health risks.
Some plaintiffs argue that they developed health issues as a direct result of using these products.
The potential settlement value for a hair relaxer cancer lawsuit can vary widely based on several factors.
Key Points:
The potential settlement value for a hair relaxer cancer lawsuit can significantly vary.
It largely depends on the specifics of the case, including the evidence presented, the jurisdiction, and the parties involved.
The severity of the plaintiff’s injuries is a crucial factor in determining the settlement value.
More severe injuries, such as advanced-stage cancer, may lead to higher settlement amounts due to increased medical costs and suffering.
The extent of the manufacturer’s alleged negligence also plays a role in determining the settlement value.
If the manufacturer is found to have knowingly concealed risks or failed to adequately warn consumers, this could increase the potential settlement amount.
To conclude, the potential settlement value for a hair relaxer cancer lawsuit can vary significantly based on the specifics of the case, the severity of the plaintiff’s injuries, and the extent of the manufacturer’s alleged negligence.
The hair relaxer cancer lawsuits typically include a range of health conditions that plaintiffs allege were caused by the use of these products.
Key Points:
The primary health condition included in hair relaxer cancer lawsuits is uterine cancer.
Plaintiffs allege that their use of hair relaxer products directly led to the development of this condition.
Endometriosis, a painful disorder in which tissue similar to the lining inside the uterus grows outside the uterus, is another condition often included in these lawsuits.
Plaintiffs claim that the use of hair relaxer products contributed to the development of this condition.
Uterine fibroids, noncancerous growths of the uterus, are also frequently mentioned in these lawsuits.
Plaintiffs allege that their use of hair relaxer products led to the development of these fibroids.
To conclude, the hair relaxer cancer lawsuits typically include health conditions such as uterine cancer, endometriosis, and uterine fibroids.
Plaintiffs allege these conditions were caused by the use of hair relaxer products.
The potential increase in the risk of uterine cancer due to frequent use of hair relaxers is a topic of ongoing research.
Key Points:
Research indicates that the regular use of hair relaxers might increase the risk of uterine cancer.
This potential link is a cause for concern and warrants further investigation.
It’s important to note that individual risk can vary greatly.
Factors such as genetic predisposition, lifestyle choices, and the frequency of product usage can all influence a person’s risk of developing uterine cancer.
While initial studies suggest a potential risk, more comprehensive research is necessary to definitively establish a correlation between the frequent use of hair relaxers and an increased risk of uterine cancer.
To conclude, while there is some evidence suggesting a higher risk of uterine cancer for frequent users of hair relaxers, more research is needed to confirm this link.
Individual risk factors also play a significant role in determining the likelihood of developing this condition.
The presence of undisclosed endocrine-disrupting chemicals in chemical hair relaxer solutions is a subject of ongoing research.
Key Points:
Some studies suggest that hair relaxer products might contain chemicals that disrupt the endocrine system.
These chemicals could potentially lead to health complications, including hormonal imbalances and related diseases.
While some research points to the presence of endocrine-disrupting chemicals in hair relaxer products, these findings require further research for confirmation.
It’s important to note that the presence and impact of these chemicals can vary based on the specific product and its formulation.
To conclude, some research suggests that hair relaxer products might contain endocrine-disrupting chemicals.
However, these findings require further research for confirmation.
The hair relaxer cancer lawsuit has prompted a variety of frequently asked questions from concerned individuals.
Key Points:
Many individuals are concerned about the potential risks of using hair relaxer products.
They often ask about the link between these products and various health conditions, including uterine cancer.
Another common question is about the procedure for filing a hair relaxer lawsuit.
Individuals want to know how they can take legal action if they believe they have been harmed by hair relaxer products.
Many individuals are curious about the potential settlement value of a hair relaxer cancer lawsuit.
They want to understand what compensation they might expect if their lawsuit is successful.
To conclude, the frequently asked questions in the hair relaxer cancer lawsuit often revolve around the potential risks of using these products, the procedure for filing a lawsuit, and the potential settlement value of a case.
Obtaining detailed information or asking specific questions related to your situation often requires professional legal consultation.
Key Points:
For specific questions or a detailed discussion about your case, it’s recommended to consult with a lawyer.
Legal professionals specializing in product liability or personal injury law can provide the most accurate and relevant advice.
A lawyer can provide personalized advice based on the specifics of your case.
This can include an evaluation of your potential claim, an explanation of your legal rights, and a discussion of possible legal strategies.
Navigating the legal process can be complex and challenging.
A lawyer can guide you through each step, from filing a hair relaxer lawsuit to negotiating a settlement or preparing for trial.
To conclude, for detailed information or specific questions related to your situation, it’s recommended to consult with a lawyer specializing in product liability or personal injury law.
They can provide personalized advice and guide you through the legal process.
Managing Attorney & Owner
With over 25 years of legal experience, Jessica Paluch-Hoerman is an Illinois lawyer, a CPA, and a mother of three. She spent the first decade of her career working as an international tax attorney at Deloitte.
In 2009, Jessie co-founded her own law firm with her husband – which has scaled to over 30 employees since its conception.
In 2016, Jessie founded TruLaw, which allows her to collaborate with attorneys and legal experts across the United States on a daily basis. This hypervaluable network of experts is what enables her to share the most reliable, accurate, and up-to-date legal information with our readers!
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?
At TruLaw, we fiercely combat corporations that endanger individuals’ well-being. If you’ve suffered injuries and believe these well-funded entities should be held accountable, we’re here for you.
With TruLaw, you gain access to successful and seasoned lawyers who maximize your chances of success. Our lawyers invest in you—they do not receive a dime until your lawsuit reaches a successful resolution!
AFFF Lawsuit claims are being filed against manufacturers of aqueous film-forming foam (AFFF), commonly used in firefighting.
Claims allege that companies such as 3M, DuPont, and Tyco Fire Products failed to adequately warn users about the potential dangers of AFFF exposure — including increased risks of various cancers and diseases.
Depo Provera Lawsuit claims are being filed by individuals who allege they developed meningioma (a type of brain tumor) after receiving Depo-Provera birth control injections.
A 2024 study found that women using Depo-Provera for at least 1 year are five times more likely to develop meningioma brain tumors compared to those not using the drug.
Suboxone Tooth Decay Lawsuit claims are being filed against Indivior, the manufacturer of Suboxone, a medication used to treat opioid addiction.
Claims allege that Indivior failed to adequately warn users about the potential dangers of severe tooth decay and dental injuries associated with Suboxone’s sublingual film version.
Social Media Harm Lawsuits are being filed against social media companies for allegedly causing mental health issues in children and teens.
Claims allege that companies like Meta, Google, ByteDance, and Snap designed addictive platforms that led to anxiety, depression, and other mental health issues without adequately warning users or parents.
Transvaginal Mesh Lawsuits are being filed against manufacturers of transvaginal mesh products used to treat pelvic organ prolapse (POP) and stress urinary incontinence (SUI).
Claims allege that companies like Ethicon, C.R. Bard, and Boston Scientific failed to adequately warn about potential dangers — including erosion, pain, and infection.
Bair Hugger Warming Blanket Lawsuits involve claims against 3M — alleging their surgical warming blankets caused severe infections and complications (particularly in hip and knee replacement surgeries).
Plaintiffs claim 3M failed to warn about potential risks — despite knowing about increased risk of deep joint infections since 2011.
Baby Formula NEC Lawsuit claims are being filed against manufacturers of cow’s milk-based baby formula products.
Claims allege that companies like Abbott Laboratories (Similac) and Mead Johnson & Company (Enfamil) failed to warn about the increased risk of necrotizing enterocolitis (NEC) in premature infants.
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?